Topiclo 0.05% (Lotion)
Medicine Details
Category | Details |
---|---|
Generic | Clobetasol propionate |
Company | Eskayef pharmaceuticals ltd |
Also available as |
Indications
- Psoriasis (excluding widespread plaque psoriasis)
- Recalcitrant dermatoses
- Lichen planus
- Discoid lupus erythematosus
- Other skin conditions which do not respond satisfactorily to less potent steroids
Composition
- Clobetasol Propionate Cream: Each gram cream contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Ointment: Each gram ointment contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Scalp Application: Each gram lotion contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Shampoo: Each gram shampoo contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Lotion: Each gram lotion contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Spray: Each gram spray contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
Pharmacology
Very potent topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties
Dosage
- Super-high potency topical corticosteroids; treatment should be limited to 2 consecutive weeks
- Cream and Ointment: Apply a thin layer twice daily, maximum weekly dose should not exceed 50 gm/week
- Spray: Apply once or twice daily to affected areas of the scalp, total dose applied should not exceed 50 ml weekly
- Shampoo: Apply to the dry scalp once a day, treatment should be limited to 4 consecutive weeks
- Scalp Solution: Apply once or twice daily to affected areas of the scalp, total dose applied should not exceed 50 ml weekly
Administration
Route of administration: Cutaneous. Creams are appropriate for moist or weeping surfaces, while ointments are appropriate for dry, lichenified, or scaly lesions
Interaction
Co-administered drugs that can inhibit CYP3A4 may inhibit the metabolism of corticosteroids leading to increased systemic exposure
Contraindications
- Rosacea, acne vulgaris, and perioral dermatitis
- Hypersensitivity to the preparation
- Not indicated for infected skin lesions, perianal and genital pruritus
- Dermatoses in children under one year of age
Side Effects
Prolonged use or treatment of extensive areas can result in systemic absorption. Local atrophic changes, pustular form of psoriasis, pigmentation changes, and hypertrichosis reported
Pregnancy & Lactation
Limited data in pregnant women, caution should be exercised during pregnancy and lactation
Precautions & Warnings
- Long-term continuous therapy should be avoided, particularly in infants and children
- Atrophic changes may occur after prolonged treatment on the face
- Care needed to prevent entry into the eye when applied to eyelids
- Appropriate anti-microbial therapy should be used for inflammatory lesions
Use in Special Populations
Long-term continuous topical corticosteroid therapy should be avoided in infants and children under 12 years of age
Overdose Effects
Acute overdosage is unlikely. Chronic over-dosage may lead to features of hypercortisolism
Therapeutic Class
Topical corticosteroids
Storage Conditions
Keep below 30°C, protected from light and moisture, do not freeze